Segall Bryant & Hamill LLC Sells 40,345 Shares of NeoGenomics, Inc. (NASDAQ:NEO)
Segall Bryant & Hamill LLC decreased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) by 50.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 39,654 shares of the medical research company’s stock after selling 40,345 shares during the quarter. Segall Bryant […]
United States Mark Mallon Dekabank Deutsche Girozentrale Kathrynb Mckenzie Craig Hallum Segall Bryant Hamill
Source: etfdailynews.com